|
[Related PubMed/MEDLINE] Total Number of Papers: 16
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2019 |
2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and alpha2-adrenergic receptors. |
2-AI, MDAI, MDMA, SERT |
2 |
2017 |
Pharmacological profile of mephedrone analogs and related new psychoactive substances. |
3-MMC, 4-MA, N-methyl-2-AI |
3 |
2017 |
Synthetic Aminoindanes: A Summary of Existing Knowledge. |
2-AI, 5-IAI, EDND, MDAI, MDMAI, WoS |
4 |
2011 |
Aminoindanes--the next wave of 'legal highs'? |
5-IAI, MDAI, MDMAI |
5 |
2002 |
Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. |
--- |
6 |
1999 |
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action. |
MTA |
7 |
1996 |
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA). |
ACTH, MTA |
8 |
1996 |
Reinforcing effects of certain serotonin-releasing amphetamine derivatives. |
CPP, DA, MDMA |
9 |
1995 |
Psychostimulant-like effects of p-fluoroamphetamine in the rat. |
DOPAC, HVA |
10 |
1994 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. |
--- |
11 |
1993 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. |
DOPA, MDMA |
12 |
1993 |
Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. |
MDMA, MMA |
13 |
1993 |
Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. |
--- |
14 |
1992 |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. |
5-HIAA, MDMA, MTA, PCA, S-MBDB |
15 |
1991 |
Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats. |
DA |
16 |
1991 |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. |
DA, MDMA, MMA, NE, S-MBDB |
|